Table 1.
Participant Baseline Characteristics
| Premenopause | Perimenopause | Postmenopause | |||
|---|---|---|---|---|---|
| High-fit (n=11) | Low-fit (n=7) | High-fit (n=12) | Low-fit (n=8) | High-fit (n=13) | |
| Age (yrs) | 44.5 ± 1.0 | 47.3 ± 1.5 | 50.8 ± 1.0b | 58.9 ± 1.4 | 60.5 ± 1.0b,c |
| Height (cm) | 163.5 ± 1.2 | 163.7 ± 3.1 | 165.4 ± 2.0 | 166.5 ± 3.1 | 161.6 ± 2.3 |
| Weight (kg) | 61.8 ± 2.2 | 72.9 ± 7.2 | 62.5 ± 3.0 | 69.0 ± 4.3 | 58.2 ± 2.5a |
| Estradiol (pg/ml) | 58.7 ± 10.7 | 117.3 ± 27.1 | 75.2 ± 32.7 | 16.5 ± 9.0 | 6.7 ± 4.2b |
| FSH (mIU/mL) | 8.5 ± 2.2 | 49.9 ± 14.0 | 66.6 ± 17.9b | 104.2 ± 8.1 | 102.6 ± 9.5b |
| Body Fat (%) | 29.6 ± 2.5 | 40.8 ± 2.6 | 26.9 ± 2.1a | 41.9 ± 1.5 | 28.0 ± 2.1a |
| BMI (kg/m2) | 23.1 ± 0.7 | 27.0 ± 2.3 | 22.7 ± 0.7a | 24.8 ± 1.3 | 22.2 ± 0.7 |
| HDL-C (mg/dL) | 71.2 ± 4.9 | 70.4 ± 9.7 | 82.0 ± 4.8 | 78.4 ± 4.8 | 94.7 ± 2.8a,b |
| LDL-C (mg/dL) | 101.9 ± 7.0 | 84.7 ± 8.4 | 98.8 ± 6.1 | 116.5 ± 9.5 | 117.1 ± 7.2 |
| TG (mg/dL) | 50.1 ± 5.8 | 52.0 ± 6.9 | 40.6 ± 7.1 | 46.4 ± 5.7 | 42.8 ± 3.6 |
| FPG (mg/dL) | 94.5 ± 2.0 | 92.4 ± 3.0 | 93.9 ± 1.8 | 99.5 ± 1.7 | 96.5 ± 1.9 |
| SBP (mmHg) | 102.7 ± 2.4 | 104.6 ± 5.6 | 106.0 ± 2.8 | 117.3 ± 5.2 | 106.3 ± 3.7 |
| DBP (mmHg) | 58.9 ± 1.5 | 64.6 ± 4.5 | 59.2 ± 1.8 | 64.6 ± 2.7 | 61.9 ± 2.3 |
| MVPA (MET-min/wk) | 3446.6 ± 429.5 | 293.1 ± 98.0 | 3695.9 ± 528.5a | 100.3 ± 40.9 | 4107.1 ± 684.1a |
| VO2 peak (ml/kg/min) | 47.0 ± 2.4 | 30.1 ± 1.6 | 49.1 ± 2.4a | 28.3 ±1.1 | 43.8 ± 1.8a |
Differences in participant characteristics were assessed between groups using one-way ANOVAs, independent t-tests, or an equivalent non-parametric test. FSH: follicle-stimulating hormone, BMI: body mass index, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, TG: triglycerides, FPG: fasting plasma glucose, SBP: systolic blood pressure, DBP: diastolic blood pressure; MVPA: moderate-to-vigorous physical activity.
a
different than low-fit group;
b
different than high-fit premenopausal group;
c
different than high-fit perimenopausal group. Data are presented as mean±SEM.